NAPINDER DHILLON: Open Payments
NPI 1558062398 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 23 payments from 9 companies in 2025. Trend: 2023 $118 · 2024 $402 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $233 |
| ABBVIE INC. | 2 | $52 |
| Exact Sciences Corporation | 2 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Dexcom, Inc. | 2 | $36 |
| Novo Nordisk Inc | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Amgen Inc. | 1 | $15 |
Products named: MOUNJARO, QULIPTA, The Cologuard Plus Collection Kit, TZIELD, Dexcom G6 Transmitter, Ozempic, SHINGRIX, FANAPT.
Industry payments across CA — which companies pay providers there.
